<DOC>
	<DOCNO>NCT02201225</DOCNO>
	<brief_summary>This methodology study evaluate sensitivity use sit knee digital caliper measure change sit knee length 12-week study period amidst child age 6 12 year community-based study child age 6 12 year receive nutritional supplementation micronutrient without micronutrient .</brief_summary>
	<brief_title>A Methodology Study Evaluate Sitting Knee Measuring Device Assessing Growth Indian Children .</brief_title>
	<detailed_description />
	<mesh_term>Micronutrients</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<criteria>Children ( participant ) , boys girl , age 6 12 year . Participant height within 25th 75th percentile standard height average Indian child population Participant agree take nutritional supplement product study except trial supplement Participant follow medical condition : Genetic disorder , chronic disease , metabolic disorder , endocrine disorder , immobilisation , miscellaneous Participant past 6 month use dietary nutritional supplement micronutrient fortification , form dietary herbal supplement intend increase micronutrient intake , frequency great 34times per month . Participant receive supplement ( calcium , iron and/or multivitamin time screen ) . Children ( Participant ) Care allow participate study . Allergy/Intolerance : Known suspected intolerance hypersensitivity study material ( closely relate compound ) state ingredient . Health condition would affect food metabolism include follow food allergy , kidney disease , liver disease , and/or gastrointestinal disease ( e.g . irritable bowel syndrome , celiac disease , peptic ulcer ) . Use concomitant medication , opinion Principal Investigator ( PI ) , might interfere outcome study increase risk participant , include corticosteroid ( systemic inhale ) medication behaviourrelated disorder and/or stimulant . Current relevant history serious , severe unstable physical psychiatric illness medical disorder , include history alcohol substance abuse , would make participant unlikely fully complete study condition present undue risk study product procedures opinion PI/medical examiner . Clinical Study/Experimental Medication : Participation another clinical study receipt investigational drug within 30 day screen visit . Personnel : Currently , participant 's parents/legal guardian employee Sponsor study member immediate family .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>